Use of Double Dose Intravenous Immunoglobulin Therapy in the Treatment of Streptococcal Toxic Shock Syndrome
Case Reports in Critical Care · 2026-01 · 2026 (1)
DOI: 10.1155/crcc/9649482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Critical Care, online erschienen am 28.07.2026. Verfasst von Yuning Xue und 1 weiteren Autor:innen. Beteiligte Einrichtung: Westmead Intensive Care Service, Westmead Hospital, Westmead, Australia, nsw.gov.au. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Streptococcal toxic shock syndrome (STSS) is a life‐threatening condition with increasing incidence and high mortality worldwide. It is characterised by hypotension and multiorgan failure, resultant of invasive group A Streptococcus (GAS) infections. Intravenous immunoglobulin (IVIG) has been proposed as an adjunctive therapy that reduces mortality in patients with STSS, and is thought to exert its effects by neutralising streptococcal superantigens and exotoxins to modulate the host immune response. Currently, there is a paucity of knowledge about the efficacy of repeated dosing if patients remain unstable after the first dose of IVIG. In this report, we describe the case of a woman in her 60s with STSS and meningoencephalitis, who demonstrated an improvement in haemodynamic status after the first dose of IVIG, but subsequently had rebound of hypotension and high vasopressor requirements, which resolved after a second dose of IVIG. This case highlights the potential need for repeated dosing of IVIG in STSS, in situations where an initial improvement in haemodynamic status is followed by deterioration.
Autor:innen und Institutionen
- Westmead Intensive Care Service, Westmead Hospital, Westmead, Australia, nsw.gov.au.
- Sydney Medical School, The University of Sydney, Sydney, Australia, sydney.edu.au.
ORCID-Profile: Yuning Xue, Alex Yartsev
Zitieren
APA
Xue, Y., & Yartsev, A. (2026). Use of Double Dose Intravenous Immunoglobulin Therapy in the Treatment of Streptococcal Toxic Shock Syndrome. Case Reports in Critical Care, 2026(1). https://doi.org/10.1155/crcc/9649482
Vancouver
Xue Y, Yartsev A. Use of Double Dose Intravenous Immunoglobulin Therapy in the Treatment of Streptococcal Toxic Shock Syndrome. Case Reports in Critical Care. 2026;2026(1). doi:10.1155/crcc/9649482
BibTeX
@article{Xue2026,
author = {Xue, Yuning and Yartsev, Alex},
title = {Use of Double Dose Intravenous Immunoglobulin Therapy in the Treatment of Streptococcal Toxic Shock Syndrome},
journal = {Case Reports in Critical Care},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crcc/9649482}
}
EUVIMED